Kaarina Kowalec

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2024;11(6):1393-1404

Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis.

Kowalec K; Harder A; Dolovich C; Fitzgerald KC; Salter A; Lu Y; Bernstein CN; Bolton JM; Cutter G; Fisk JD; Gelernter J; Graff LA; Hägg S; Hitchon CA; Levey DF; Lublin FD; McKay KA; Patten S; Patki A; Stein MB; Tiwari HK; Wolinsky JS; Marrie RA
Article: NEUROLOGY. 2024;102(5):e209135

Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.

Salter A; Lancia S; Kowalec K; Fitzgerald KC; Marrie RA
Article: PHARMACOGENOMICS. 2024;25(4):175-186

Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada.

Maruf AA; Shields M; Fryza A; Wondrasek A; Leong C; Kowalec K; Bousman C
Article: HEALTH SCIENCE REPORTS. 2024;7(1):e1844

Knowledge, perceptions, and attitudes toward pharmacogenomics among pharmacists and pharmacy students: A systematic review.

Wondrasek A; Fryza A; Aziz MA; Leong C; Kowalec K; Maruf AA
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2023;180(10):714-722

Genetic Contribution to the Heterogeneity of Major Depressive Disorder: Evidence From a Sibling-Based Design Using Swedish National Registers.

Nguyen T-D; Kowalec K; Pasman J; Larsson H; Lichtenstein P; Dalman C; Sullivan PF; Kuja-Halkola R; Lu Y
Article: TRANSLATIONAL PSYCHIATRY. 2023;13(1):301

Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.

Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y
Article: JOURNAL OF PSYCHOSOMATIC RESEARCH. 2023;172:111415

Assessment of differential item functioning of the PHQ-9, HADS-D and PROMIS-depression scales in persons with and without multiple sclerosis.

Marrie RA; Lix LM; Bolton JM; Fisk JD; Fitzgerald KC; Graff LA; Hitchon CA; Kowalec K; Marriott JJ; Patten SB; Salter A; Bernstein CN; CIHR Team in Defining the Burden and Managing the
Article: NEUROLOGY. 2023;101(5):e522-e532

Polygenicity of Comorbid Depression in Multiple Sclerosis.

Kowalec K; Fitzgerald KC; Salter A; Dolovich C; Harder A; Bernstein CN; Bolton J; Cutter GR; Graff LA; Hägg S; Hitchon CA; Lu Y; Lublin F; McKay KA; Patten SB; Patki A; Tiwari HK; Wolinsky JS; Marrie RA
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2023;43(4):313-319

Adherence to Psychotropic Medication Before and During COVID-19: A Population-Wide Retrospective Observational Study.

Froese B; Aquino G; Valencia E; Tan Q; Yogendran M; Katz C; Bolton JM; Falk J; Kowalec K; Chateau D; Delaney JC; Logsetty S; Spiwak R; Enns MW; Sareen J; Alessi-Severini S; Olafson K; Eltonsy S; Leong C
Journal article: BMJ OPEN. 2023;13(6):e073782

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study.

Almweisheer S; Bernstein CN; Graff LA; Patten SB; Bolton J; Fisk JD; Hitchon CA; Marriott JJ; Marrie RA; CIHR Team in Defining the Burden and Managing the
Article: THE LANCET REGIONAL HEALTH - EUROPE. 2023;29:100621

Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers.

Pasman JA; Meijsen JJ; Haram M; Kowalec K; Harder A; Xiong Y; Nguyen T-D; Jangmo A; Shorter JR; Bergstedt J; Das U; Zetterberg R; Tate A; Lichtenstein P; Larsson H; Odsbu I; Werge T; Reichborn-Kjennerud T; Andreassen OA; Sullivan PF; Buil A; Tesli M; Lu Y
Article: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 2023;45(1):233-239

Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic.

Offiah R; Aboulatta L; Peymani P; Aloud B; Kowalec K; Leong C; Delaney J; Falk J; Alessi-Severini S; Eltonsy S
Article: BMJ PAEDIATRICS OPEN. 2023;7(1):e001686

Preterm birth and stillbirth rates associated with socioeconomic disparities during COVID-19 pandemic: a population-based cross-sectional study.

Aboulatta L; Kowalec K; Leong C; Delaney JA; Falk J; Alessi-Severini S; Chateau D; Tan Q; Kearns K; Raimondi C; Vaccaro C; Lavu A; Haidar L; Peymani P; Eltonsy S
Article: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2023;10(1):e200062

Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis.

Vasileiou ES; Hu C; Bernstein CN; Lublin F; Wolinsky JS; Cutter GR; Sotirchos ES; Kowalec K; Salter A; Saidha S; Mowry EM; Calabresi PA; Marrie RA; Fitzgerald KC
Article: FRONTIERS IN PSYCHIATRY. 2023;14:1260420

Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis.

Joyees J; Marrie RA; Bernstein CN; Bolton JM; Fisk JD; Graff LA; Hitchon C; Patten SB; Kowalec K; CIHR team in defining the burden and managing the
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2022;179(11):844-852

Association Between Polygenic Risk Scores and Outcome of ECT.

Sigström R; Kowalec K; Jonsson L; Clements CC; Karlsson R; Nordenskjöld A; Pålsson E; Sullivan PF; Landén M
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e31-e32

TRYGGVE2: SECURE & PRECISE GENETIC ANALYSES IN THE NORDIC COUNTRIES AND BEYOND

Lu Y; Kowalec K; Werge T; Andreassen O; Sullivan P
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e270

INVESTIGATING GENETIC OVERLAP BETWEEN ANTIDEPRESSANTS AND LITHIUM RESPONSE AND TREATMENT RESISTANCE IN MAJOR DEPRESSIVE DISORDER

Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Jonsson L; Clements C; Andersson E; Boberg J; Lewis C; Sullivan P; Landén M; Lu Y
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e198

T55. POLYGENICITY OF COMORBID DEPRESSION IN MULTIPLE SCLEROSIS

Kowalec K; Salter A; Fitzgerald KC; Harder A; Lu Y; Dolovich C; Hägg S; Hitchon C; Bernstein CN; Cutter G; Bolton JM; McKay K; Graff LA; Patten S; Marrie RA
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e32-e33

NEXT GENERATION GENOME-WIDE ASSOCIATION STUDY OF SCHIZOPHRENIA FROM SWEDEN

Kowalec K; Karlsson R; Lu Y; Song J; Yao S; Szatkiewicz J; Kähler A; Schalling M; Österholm A-M; Hultman C; Lavebratt C; Landen M; Karlsson H; Dalman C; Sullivan P
Article: GENERAL HOSPITAL PSYCHIATRY. 2022;77:21-28

Depressive symptom trajectories and polygenic risk scores in individuals with an immune-mediated inflammatory disease.

Kowalec K; Salter A; Fitzgerald KC; Patel M; Han J; Lu Y; Bolton JM; Hitchon C; Bernstein CN; Patten S; Graff LA; Marriott JJ; Marrie RA; CIHR Team in Defining the Burden and Managing the
Article: BMC RESEARCH NOTES. 2022;15(1):162

Trends of COVID-19 incidence in Manitoba and public health measures: March 2020 to February 2022.

Aboulatta L; Kowalec K; Delaney J; Alessi-Severini S; Leong C; Falk J; Eltonsy S
Article: MOLECULAR PSYCHIATRY. 2022;27(5):2439-2447

The impact of educational attainment, intelligence and intellectual disability on schizophrenia: a Swedish population-based register and genetic study.

Song J; Yao S; Kowalec K; Lu Y; Sariaslan A; Szatkiewicz JP; Larsson H; Lichtenstein P; Hultman CM; Sullivan PF
Article: MOLECULAR PSYCHIATRY. 2022;27(3):1667-1675

Genetic heterogeneity and subtypes of major depression.

Nguyen T-D; Harder A; Xiong Y; Kowalec K; Hägg S; Cai N; Kuja-Halkola R; Dalman C; Sullivan PF; Lu Y
Article: JAMA PSYCHIATRY. 2022;79(3):260-269

Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.

Pardiñas AF; Smart SE; Willcocks IR; Holmans PA; Dennison CA; Lynham AJ; Legge SE; Baune BT; Bigdeli TB; Cairns MJ; Corvin A; Fanous AH; Frank J; Kelly B; McQuillin A; Melle I; Mortensen PB; Mowry BJ; Pato CN; Periyasamy S; Rietschel M; Rujescu D; Simonsen C; St Clair D; Tooney P; Wu JQ; Andreassen OA; Kowalec K; Sullivan PF; Murray RM; Owen MJ; MacCabe JH; O'Donovan MC; Walters JTR; Genetics Workstream of the Schizophrenia Treatment; Ajnakina O; Alameda L; Barnes TRE; Berardi D; Bonora E; Camporesi S; Cleusix M; Conus P; Crespo-Facorro B; D'Andrea G; Demjaha A; Do KQ; Doody GA; Eap CB; Ferchiou A; Di Forti M; Guidi L; Homman L; Jenni R; Joyce EM; Kassoumeri L; Khadimallah I; Lastrina O; Muratori R; Noyan H; O'Neill FA; Pignon B; Restellini R; Richard J-R; Schürhoff F; Španiel F; Szöke A; Tarricone I; Tortelli A; Üçok A; Vázquez-Bourgon J
Article: PLOS ONE. 2022;17(11):e0278072

Drug utilization patterns before and during COVID-19 pandemic in Manitoba, Canada: A population-based study.

Aboulatta L; Peymani P; Vaccaro C; Leong C; Kowalec K; Delaney J; Falk J; Alessi-Severini S; Aloud B; Eltonsy S
Article: FRONTIERS IN PHARMACOLOGY. 2022;13:886652

Psychotropic Medication Use Before and During COVID-19: A Population-Wide Study.

Leong C; Kowalec K; Eltonsy S; Bolton JM; Enns MW; Tan Q; Yogendran M; Chateau D; Delaney JA; Sareen J; Falk J; Spiwak R; Logsetty S; Alessi-Severini S
Article: FRONTIERS IN PHARMACOLOGY. 2022;13:871136

Trends of Utilization of Antiseizure Medications Among Pregnant Women in Manitoba, Canada: A 20-Year Population-Based Study.

Shouman W; Delaney JA; Kowalec K; Ng M; Ruth C; Falk J; Leong C; Alessi-Severini S; Lavu A; Peymani P; Eltonsy S
Article: ACR OPEN RHEUMATOLOGY. 2021;3(12):889-896

Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis.

Kowalec K; Carney H; Patel M; Hitchon C; Bolton JM; Patten SB; Graff LA; Bernstein CN; Peschken C; Marrie RA; Canadian Institutes of Health Research Team in Def
Article: MULTIPLE SCLEROSIS JOURNAL. 2021;27(13):2077-2084

Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis.

Harroud A; Marrie RA; Fitzgerald KC; Salter A; Lu Y; Patel M; Kowalec K
Article: MOLECULAR PSYCHIATRY. 2021;26(8):4487-4495

Increased schizophrenia family history burden and reduced premorbid IQ in treatment-resistant schizophrenia: a Swedish National Register and Genomic Study.

Kowalec K; Lu Y; Sariaslan A; Song J; Ploner A; Dalman C; Hultman CM; Larsson H; Lichtenstein P; Sullivan PF
Article: TRANSLATIONAL PSYCHIATRY. 2021;11(1):163

The association between family history and genomic burden with schizophrenia mortality: a Swedish population-based register and genetic sample study.

Kowalec K; Lu Y; Song J; Dalman C; Hultman CM; Larsson H; Lichtenstein P; Sullivan PF
Article: ELIFE. 2021;10:e58430

DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia.

Hannon E; Dempster EL; Mansell G; Burrage J; Bass N; Bohlken MM; Corvin A; Curtis CJ; Dempster D; Di Forti M; Dinan TG; Donohoe G; Gaughran F; Gill M; Gillespie A; Gunasinghe C; Hulshoff HE; Hultman CM; Johansson V; Kahn RS; Kaprio J; Kenis G; Kowalec K; MacCabe J; McDonald C; McQuillin A; Morris DW; Murphy KC; Mustard CJ; Nenadic I; O'Donovan MC; Quattrone D; Richards AL; Rutten BP; St Clair D; Therman S; Toulopoulou T; Van Os J; Waddington JL; Wellcome Trust Case Control Consortium (WTCCC); CRESTAR consortium; Sullivan P; Vassos E; Breen G; Collier DA; Murray RM; Schalkwyk LS; Mill J
Article: INFLAMMATORY BOWEL DISEASES. 2021;27(1):58-64

Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease.

Carney H; Marrie RA; Bolton JM; Patten SB; Graff LA; Bernstein CN; Kowalec K
Article: NEUROLOGY. 2020;95(5):e446-e456

Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.

Salter A; Kowalec K; Fitzgerald KC; Cutter G; Marrie RA
Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:s236

T36UNDERSTANDING PSYCHIATRIC COMORBIDITY IN CHRONIC IMMUNOINFLAMMATORY DISEASES USING GENOMICS

Kowalec K; Bernstein CN; Hitchon C; Bolton J; Marrie RA
Article: TRANSLATIONAL PSYCHIATRY. 2019;9(1):157

Methylation age acceleration does not predict mortality in schizophrenia.

Kowalec K; Hannon E; Mansell G; Burrage J; Ori APS; Ophoff RA; Mill J; Sullivan PF
Article: NATURE GENETICS. 2018;50(8):1081-1085

Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis.

Kowalec K; Wright GEB; Drögemöller BI; Aminkeng F; Bhavsar AP; Kingwell E; Yoshida EM; Traboulsee A; Marrie RA; Kremenchutzky M; Campbell TL; Duquette P; Chalasani N; Wadelius M; Hallberg P; Xia Z; De Jager PL; Denny JC; Davis MF; Ross CJD; Tremlett H; Carleton BC
Article: NEUROLOGY. 2018;90(4):e332-e341

Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.

McCormack M; Gui H; Ingason A; Speed D; Wright GEB; Zhang EJ; Secolin R; Yasuda C; Kwok M; Wolking S; Becker F; Rau S; Avbersek A; Heggeli K; Leu C; Depondt C; Sills GJ; Marson AG; Auce P; Brodie MJ; Francis B; Johnson MR; Koeleman BPC; Striano P; Coppola A; Zara F; Kunz WS; Sander JW; Lerche H; Klein KM; Weckhuysen S; Krenn M; Gudmundsson LJ; Stefánsson K; Krause R; Shear N; Ross CJD; Delanty N; EPIGEN Consortium; ; Pirmohamed M; Carleton BC; Canadian Pharmacogenomics Network for Drug Safety; ; Cendes F; Lopes-Cendes I; Liao W-P; O'Brien TJ; Sisodiya SM; EpiPGX Consortium; ; Cherny S; Kwan P; Baum L; International League Against Epilepsy Consortium o; Cavalleri GL
Article: NEUROLOGY. 2017;89(24):2455-2461

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.

Kowalec K; McKay KA; Patten SB; Fisk JD; Evans C; Tremlett H; Marrie RA; CIHR Team in Epidemiology and Impact of Comorbidit
Journal article: JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. 2017;88:173

Genome-wide Scan Identifies Association Between an Interferon Regulatory Factor Variant and Interferon-beta Induced Liver Injury in Multiple Sclerosis Patients

Kowalec K; Wright GEB; Drögemöller BI; Aminkeng F; Bhavsar AP; Kingwell E; Yoshida EM; Traboulsee A; Marrie RA; Kremenchutzky M; Campbell TL; Duquette P; Chalasani N; Wadelius M; Hallberg P; Xia Z; De Jager P; Ross C; Tremlett H; Carleton B
Journal article: JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. 2017;88:167

Pharmacogenomic Prediction of Ribavirin-Induced Hemolytic Anemia in Patients Treated for Hepatitis C Infection

Abel S; Aminkeng F; Kowalec K; Drogemoller B; Wright G; Bader R; Stortz J; Yoshida E; Lee S; Al-Judaibi B; Kim R; Tam E; Ramji A; Ross C; Carleton B
Article: BMJ OPEN. 2017;7(5):e016276

Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia.

Kowalec K; Kingwell E; Carruthers R; Marrie RA; Bernatsky S; Traboulsee A; Ross CJD; Carleton B; Tremlett H
Article: DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. 2016;85(3):328-333

Discordant diagnostic results due to a hepatitis B virus T123A HBsAg mutant.

Osiowy C; Kowalec K; Giles E
Article: NATURE GENETICS. 2015;47(9):1079-1084

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer.

Aminkeng F; Bhavsar AP; Visscher H; Rassekh SR; Li Y; Lee JW; Brunham LR; Caron HN; van Dalen EC; Kremer LC; van der Pal HJ; Amstutz U; Rieder MJ; Bernstein D; Carleton BC; Hayden MR; Ross CJD; Canadian Pharmacogenomics Network for Drug Safety
Article: JOURNAL OF VIRAL HEPATITIS. 2013;20(2):122-130

Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals.

Kowalec K; Minuk GY; Børresen ML; Koch A; McMahon BJ; Simons B; Osiowy C
Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2013;2(1):57-59

Suspected autoimmune hepatitis and primary biliary cirrhosis unmasked by interferon-beta in a multiple sclerosis patient.

Kowalec K; Yoshida EM; Traboulsee A; Carleton B; Tremlett H
Article: JOURNAL OF MEDICAL VIROLOGY. 2012;84(9):1369-1375

The prevalence and long term outcome of occult hepatitis B virus infections in community based populations.

Minuk GY; Kowalec K; Caouette S; Larke B; Osiowy C
Article: JOURNAL OF MEDICAL VIROLOGY. 2010;82(6):942-948

Molecular characterization of hepatitis B virus and a 9-year clinical profile in a patient infected with genotype I.

Osiowy C; Kaita K; Solar K; Mendoza K
Visa fler

Alla övriga publikationer

Preprint: MEDRXIV. 2023

Subtyping Schizophrenia Using Psychiatric Polygenic Scores

Lu Y; Kowalec K; Song J; Karlsson R; Harder A; Giusti-Rodríguez P; Sullivan PF; Yao S
Preprint: RES SQ. 2023;RES SQ

Investigating genetic overlap between antidepressant and lithium response and treatment resistance in major depressive disorder.

Lu Y; Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigstrom R; Jonsson L; Clements C; Andersson E; Boberg J; Lewis C; Sullivan P; Landén M
Review: FRONTIERS IN IMMUNOLOGY. 2023;14:1197195

Etiology, effects and management of comorbidities in multiple sclerosis: recent advances.

Marrie RA; Fisk JD; Fitzgerald K; Kowalec K; Maxwell C; Rotstein D; Salter A; Tremlett H
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:E159

POLYGENIC RISK AND BODY MASS INDEX IN THE SWE-DEN SCHIZOPHRENIA STUDY

Kowalec K; Song J; Yao S; Karlsson R; Lu Y; Bergen S; Harder A; Kahler A; Osterholm A-M; Hultman C; Sullivan P
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:E50

GENETIC EPIDEMIOLOGY AND POLYGENICITY OF PSYCHOTIC MAJOR DEPRESSIVE DISORDER

Thi TDN; Kuja-Halkola R; Kowalec K; Harder A; Xiong Y; Landen M; Hagg S; Lichtenstein P; Larsson H; Buil A; Meijsen J; Sullivan P; Dalman C; Pasman J; Lu Y
Preprint: MEDRXIV. 2022

COVID-19 pandemic impact on preterm birth and stillbirth rates associated with socioeconomic disparities: A quasi-experimental study

Aboulatta L; Kowalec K; Leong C; Delaney J; Falk J; Alessi-Severini S; Chateau D; Tan Q; Kearns K; Raimondi C; Lavu A; Haidar L; Vaccaro C; Eltonsy S
Review: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2022;111(4):919-930

A Systematic Review and Analysis of the Use of Polygenic Scores in Pharmacogenomics.

Johnson D; Wilke MAP; Lyle SM; Kowalec K; Jorgensen A; Wright GEB; Drögemöller BI
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(1_SUPPL):52

Biostatistical Methods

Hu C; Marrie RA; Salter A; Kowalec K; Fitzgerald K
Conference publication: BIRTH DEFECTS RESEARCH. 2022;114(9):395

Impact of COVID-19 Pandemic on Preterm Birth and Stillbirth Rates in Manitoba, Canada: A Quasi-Experimental Study

Aboulatta L; Kowalec K; Leong C; Delaney J; Falk J; Alessi-Severini S; Eltonsy S
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):212

Polygenicity of comorbid depression in multiple sclerosis

Kowalec K; Salter A; Fitzgerald KC; Harder A; Lu Y; Dolovich C; Hagg S; Hitchon C; Bernstein CN; Cutter G; Marriott JJ; Bolton JM; McKay K; Graff LA; Patten S; Marrie RA
Review: PSYCHOLOGICAL MEDICINE. 2021;51(13):2168-2177

Genetic architecture of schizophrenia: a review of major advancements.

Legge SE; Santoro ML; Periyasamy S; Okewole A; Arsalan A; Kowalec K
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;51:E137-E138

THE IMPACT OF EDUCATIONAL ATTAINMENT, IN-TELLIGENCE AND INTELLECTUAL DISABILITY ON SCHIZOPHRENIA: A SWEDISH POPULATION-BASED REGISTER AND GENETIC STUDY

Song J; Yao S; Kowalec K; Lu Y; Sariaslan A; Szatkiewicz J; Larsson H; Lichtenstein P; Hultman C; Sullivan P
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;51:E237

CLUSTERING OF SCHIZOPHRENIA CASES BASED ON COMMON GENETIC VARIANTS

Yao S; Lu Y; Kowalec K; Song J; Karlsson R; Harder A; Sullivan P
Preprint: MEDRXIV. 2021

Genetic heterogeneity and subtypes of major depression

Nguyen T-D; Harder A; Xiong Y; Kowalec K; Hägg S; Cai N; Kuja-Halkola R; Dalman C; Sullivan P; Lu Y
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(1_SUPPL):58-59

Mendelian Randomization Provides No Evidence for a Causal Role in the Bidirectional Relationship Between Depression and Multiple Sclerosis

Harroud A; Marrie R; Richards B; Fitzgerald K; Salter A; Lu Y; Patel M; Kowalec K
Preprint: BIORXIV. 2020

Large-scale analysis of DNA methylation identifies cellular alterations in blood from psychosis patients and molecular biomarkers of treatment-resistant schizophrenia

Hannon E; Dempster EL; Mansell G; Burrage J; Bass N; Bohlken MM; Corvin A; Curtis CJ; Dempster D; Di Forta M; Dinan TG; Donohoe G; Gaughran F; Gill M; Gillespie A; Gunasinghe C; Hulshoff HE; Hultman CM; Johansson V; Kahn RS; Kaprio J; Kenis G; Kowalec K; MacCabe J; McDonald C; McQuillin A; Morris DW; Murphy KC; Mustard C; Nenadic I; O’Donovan MC; Quattrone D; Richards AL; Rutten BP; St Clair D; Therman S; Toulopoulou T; Van Os J; Waddington JL; Consortium WTCC; consortium CA; Sullivan P; Vassos E; Breen G; Collier DA; Murray R; Schalkwyk LS; Mill J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S184

TRYGGVE2: PREDICTING POOR OUTCOMES IN MAJOR DEPRESSION USING REGISTER GENOMICS IN SWEDEN

Lu Y; Kowalec K; Drange OK; Tesli M; Weinsheimer S; Folkersen L; Werge T; Andreassen O; Reichborn-Kjennerud T; Sullivan P
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S85-S86

TRYGGVE2: PREDICTING POOR OUTCOMES IN SCHIZOPHRENIA USING REGISTER GENOMICS IN SWEDEN

Kowalec K; Yi L; Drange OK; Weinsheimer S; Tesli M; Folkersen L; Werge T; Andreassen OA; Reichborn-Kjennerud T; Sullivan P
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S215

INCREASED SCHIZOPHRENIA FAMILY HISTORY BURDEN AND REDUCED PREMORBID IQ IN TREATMENT-RESISTANT SCHIZOPHRENIA: A SWEDISH NATIONAL REGISTER AND GENOMIC STUDY

Kowalec K; Yi L; Sariaslan A; Song J; Ploner A; Dalman C; Hultman C; Larsson H; Lichtenstein P; Sullivan P
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:648

Understanding psychiatric comorbidity in multiple sclerosis using genomics

Kowalec K; Bernstein CN; Hitchon C; Bolton J; Marrie RA
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:1099-1100

METHYLOMIC BIOMARKERS OF SCHIZOPHRENIA AND ANTIPSYCHOTIC MEDICATION EXPOSURE

Hannon E; Dempster E; Mansell G; Schalkwyk L; Murray R; McQuillin A; Kowalec K; St Clair D; Morris D; Sullivan P; O'Donovan M; MacCabe J; Collier D; Mill J
Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:1332-1333

PREDICTION OF MORTALITY USING DNA METHYLATION AGE IN SCHIZOPHRENIA

Kowalec K; Hannon E; Mansell G; Burrage J; Mill J; Sullivan P
Editorial comment: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2017;12:1-3

From bugs to brains: The microbiome in neurological health.

McKay KA; Kowalec K; Brinkman F; Finlay BB; Horwitz M; Manges AR; Osborne L; Tremlett H
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:991

Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study

Kowalec K; McKay K; Patten SB; Fisk JD; Evans C; Tremlett H; Marrie RA
Review: EXPERT OPINION ON DRUG SAFETY. 2014;13(10):1305-1317

Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients.

Kowalec K; Kingwell E; Yoshida EM; Marrie RA; Kremenchutzky M; Campbell TL; Wadelius M; Carleton B; Tremlett H
Review: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2013;2(3):183-192

The potential role of pharmacogenomics in the prevention of serious adverse drug reactions in multiple sclerosis.

Kowalec K; Carleton B; Tremlett H
Visa fler

Forskningsbidrag

Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada

Canadian Institutes of Health Research

1 January 2023 - 31 December 2023
Precision Genomics Suite

Canada Foundation for Innovation

22 November 2022
Psychiatric Disorder Genomic Risk Scores as a Correlate of Disease Activity and Progression in Multiple Sclerosis

Congressionally Directed Medical Research Programs

15 July 2020 - 14 July 2024
Enhancing CAN-AIM capacity to respond to drug safety and effectiveness queries

Canadian Institutes of Health Research

1 September 2019 - 31 August 2022
Identifying Clinical, Demographic, & Genomic Risk Factors for Treatment-Resistant Psychiatric Disorders

Canadian Institutes of Health Research

1 April 2018 - 3 January 2019
The Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program

Canadian Institutes of Health Research

1 November 2015 - 28 February 2022
Genotype specific approaches to beta-interferon therapy in Multiple Sclerosis

Canadian Institutes of Health Research

1 May 2011 - 31 October 2014

Anställningar

Assistant Professor, Genetics, University of Manitoba, 2019-
Anknuten till Forskning, Medicinsk epidemiologi och biostatistik, Karolinska Institutet, 2022-2025

Examina och utbildning

PhD, Genetics and epidemiology, University of British Columbia, 2016
MSc, Viral genetics, University of Manitoba, 2011
BSc, Microbiology, University of Manitoba, 2008

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI